Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Zappulo

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Microbial Pathogenesis|January 10, 2023
Microbiota and hepatitis C virus in the era of direct-acting antiviral agentsBiagio Pinchera, Nicola Schiano Moriello, Antonio Riccardo Buonomo, et al.
Antiviral Therapy|April 17, 2026
Combination antiviral and anti-CMV immunoglobulin therapy for CMV infection: A case-control studyBiagio Pinchera, Ludovica Fusco, Vincenzo Fotticchia, et al.
Microorganisms|January 28, 2026
What Drives Mortality in <i>S. maltophilia</i> Bloodstream Infections? An Outcome-Focused Cohort Study of Treatment Strategies and Resistance ProfilesEmanuela Zappulo, Nicola Schiano Moriello, Rossella Paolillo, et al.
Reviews on Recent Clinical Trials|July 18, 2013
Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New EraIvan Gentile, Federico Borgia, Emanuela Zappulo, et al.
Therapeutics and Clinical Risk Management|July 26, 2014
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 15, 2017
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosisAntonio Riccardo Buonomo, Emanuela Zappulo, Riccardo Scotto, et al.
Critical Reviews in Oncology/Hematology|June 16, 2024
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitorsFrancesca R Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Blood Reviews|February 8, 2024
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelinesMalgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
In Vivo (Athens, Greece)|December 28, 2018
Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCCAntonio Riccardo Buonomo, Riccardo Scotto, Emanuela Zappulo, et al.
Reviews on Recent Clinical Trials|March 9, 2019
Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus InfectionRiccardo Scotto, Antonio Riccardo Buonomo, Nicola Schiano Moriello, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Microbial Pathogenesis|January 10, 2023
Microbiota and hepatitis C virus in the era of direct-acting antiviral agentsBiagio Pinchera, Nicola Schiano Moriello, Antonio Riccardo Buonomo, et al.
Antiviral Therapy|April 17, 2026
Combination antiviral and anti-CMV immunoglobulin therapy for CMV infection: A case-control studyBiagio Pinchera, Ludovica Fusco, Vincenzo Fotticchia, et al.
Microorganisms|January 28, 2026
What Drives Mortality in <i>S. maltophilia</i> Bloodstream Infections? An Outcome-Focused Cohort Study of Treatment Strategies and Resistance ProfilesEmanuela Zappulo, Nicola Schiano Moriello, Rossella Paolillo, et al.
Reviews on Recent Clinical Trials|July 18, 2013
Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New EraIvan Gentile, Federico Borgia, Emanuela Zappulo, et al.
Therapeutics and Clinical Risk Management|July 26, 2014
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 15, 2017
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosisAntonio Riccardo Buonomo, Emanuela Zappulo, Riccardo Scotto, et al.
Critical Reviews in Oncology/Hematology|June 16, 2024
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitorsFrancesca R Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Blood Reviews|February 8, 2024
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelinesMalgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
In Vivo (Athens, Greece)|December 28, 2018
Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCCAntonio Riccardo Buonomo, Riccardo Scotto, Emanuela Zappulo, et al.
Reviews on Recent Clinical Trials|March 9, 2019
Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus InfectionRiccardo Scotto, Antonio Riccardo Buonomo, Nicola Schiano Moriello, et al.
Pageof 8